Statistically, the colon and lung cancer specimens expressed comparable mTOR levels when compared to PCa samples in the TMA, while breast cancer specimens expressed lower levels of mTOR protein than the PCa specimens (Figure 4A). This evidence concerns the gene MTOR and posterior cortical atrophy.